» Articles » PMID: 36226052

Radioprotection of Deinococcal Exopolysaccharide BRD125 by Regenerating Hematopoietic Stem Cells

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Oct 13
PMID 36226052
Authors
Affiliations
Soon will be listed here.
Abstract

There is a substantial need for the development of biomaterials for protecting hematopoietic stem cells and enhancing hematopoiesis after radiation damage. Bacterial exopolysaccharide (EPS) has been shown to be very attractive to researchers as a radioprotectant owing to its high antioxidant, anti-cancer, and limited adverse effects. In the present study, we isolated EPS from a novel strain, BRD125, which produces EPS in high abundance, and investigated its applicability as a radioprotective biomaterial. We found that EPS isolated from EPS-rich BRD125 (DeinoPol-BRD125) had an excellent free-radical scavenging effect and reduced irradiation-induced apoptosis. In addition, bone-marrow and spleen-cell apoptosis in irradiated mice were significantly reduced by DeinoPol-BRD125 administration. DeinoPol-BRD125 enhanced the expression of hematopoiesis-related cytokines such as GM-CSF, G-GSF, M-CSF, and SCF, thereby enhancing hematopoietic stem cells protection and regeneration. Taken together, our findings are the first to report the immunological mechanism of a novel radioprotectant, DeinoPol-BRD125, which might constitute an ideal radioprotective and radiation mitigating agent as a supplement drug during radiotherapy.

Citing Articles

Comparative genomics of : unveiling genetic discrepancies between ATCC 13939K and BAA-816 strains.

Jeong S, Singh H, Jung J, Jung K, Ryu S, Lim S Front Microbiol. 2024; 15:1410024.

PMID: 38962131 PMC: 11219805. DOI: 10.3389/fmicb.2024.1410024.

References
1.
Weisburg W, Barns S, Pelletier D, Lane D . 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol. 1991; 173(2):697-703. PMC: 207061. DOI: 10.1128/jb.173.2.697-703.1991. View

2.
Kouvaris J, Kouloulias V, Vlahos L . Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist. 2007; 12(6):738-47. DOI: 10.1634/theoncologist.12-6-738. View

3.
Franken N, Rodermond H, Stap J, Haveman J, van Bree C . Clonogenic assay of cells in vitro. Nat Protoc. 2007; 1(5):2315-9. DOI: 10.1038/nprot.2006.339. View

4.
Wang X, Zhang Y, Liu Z, Zhao M, Liu P . Purification, Characterization, and Antioxidant Activity of Polysaccharides Isolated from Cortex Periplocae. Molecules. 2017; 22(11). PMC: 6150556. DOI: 10.3390/molecules22111866. View

5.
Ceccarelli S, Romano F, Angeloni A, Marchese C . Potential dual role of KGF/KGFR as a target option in novel therapeutic strategies for the treatment of cancers and mucosal damages. Expert Opin Ther Targets. 2012; 16(4):377-93. DOI: 10.1517/14728222.2012.671813. View